| Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 1211 | 2019 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment V Roessner, KJ Plessen, A Rothenberger, AG Ludolph, R Rizzo, L Skov, ... European child & adolescent psychiatry 20, 173-196, 2011 | 556 | 2011 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions C Verdellen, J van de Griendt, A Hartmann, T Murphy, ... European child & adolescent psychiatry 20, 197-207, 2011 | 387 | 2011 |
| Interrogating the genetic determinants of Tourette’s syndrome and other tic disorders through genome-wide association studies D Yu, JH Sul, F Tsetsos, MS Nawaz, AY Huang, I Zelaya, C Illmann, ... American Journal of Psychiatry 176 (3), 217-227, 2019 | 343 | 2019 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment DC Cath, T Hedderly, AG Ludolph, JS Stern, T Murphy, A Hartmann, ... European child & adolescent psychiatry 20, 155-171, 2011 | 313 | 2011 |
| Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate … L Hennissen, MJ Bakker, T Banaschewski, S Carucci, D Coghill, ... CNS drugs 31, 199-215, 2017 | 271 | 2017 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation KR Müller-Vahl, DC Cath, AE Cavanna, S Dehning, M Porta, ... European child & adolescent psychiatry 20, 209-217, 2011 | 207 | 2011 |
| Rare copy number variants in NRXN1 and CNTN6 increase risk for Tourette syndrome AY Huang, D Yu, LK Davis, JH Sul, F Tsetsos, V Ramensky, I Zelaya, ... Neuron 94 (6), 1101-1111. e7, 2017 | 201 | 2017 |
| Pandemic-related emergency psychiatric presentations for self-harm of children and adolescents in 10 countries (PREP-kids): a retrospective international cohort study D Ougrin, BH Wong, M Vaezinejad, PL Plener, T Mehdi, L Romaniuk, ... European child & adolescent psychiatry, 1-13, 2021 | 140 | 2021 |
| Association of risk of suicide attempts with methylphenidate treatment KKC Man, D Coghill, EW Chan, WCY Lau, C Hollis, E Liddle, ... JAMA psychiatry 74 (10), 1048-1055, 2017 | 137 | 2017 |
| De novo sequence and copy number variants are strongly associated with Tourette disorder and implicate cell polarity in pathogenesis S Wang, JD Mandell, Y Kumar, N Sun, MT Morris, J Arbelaez, C Nasello, ... Cell reports 24 (13), 3441-3454. e12, 2018 | 135 | 2018 |
| Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families I Karagiannidis, S Dehning, P Sandor, Z Tarnok, R Rizzo, T Wolanczyk, ... Journal of medical genetics 50 (11), 760-764, 2013 | 131 | 2013 |
| European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment V Roessner, H Eichele, JS Stern, L Skov, R Rizzo, NM Debes, P Nagy, ... European child & adolescent psychiatry, 1-17, 2022 | 125 | 2022 |
| Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence H Krinzinger, CL Hall, MJ Groom, MT Ansari, T Banaschewski, ... Neuroscience & Biobehavioral Reviews 107, 945-968, 2019 | 112 | 2019 |
| Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis S Carucci, C Balia, A Gagliano, A Lampis, JK Buitelaar, M Danckaerts, ... Neuroscience & Biobehavioral Reviews 120, 509-525, 2021 | 98 | 2021 |
| Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase … RW Dittmann, E Cardo, P Nagy, CS Anderson, R Bloomfield, B Caballero, ... CNS drugs 27, 1081-1092, 2013 | 94 | 2013 |
| Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families I Karagiannidis, R Rizzo, Z Tarnok, T Wolanczyk, J Hebebrand, ... Molecular psychiatry 17 (7), 665-668, 2012 | 85 | 2012 |
| Genetic association signal near NTN4 in Tourette syndrome P Paschou, D Yu, G Gerber, P Evans, F Tsetsos, LK Davis, I Karagiannidis, ... Annals of neurology 76 (2), 310-315, 2014 | 77 | 2014 |
| Emotion recognition pattern in adolescent boys with attention‐deficit/hyperactivity disorder N Aspan, C Bozsik, J Gadoros, P Nagy, J Inantsy-Pap, P Vida, J Halasz BioMed research international 2014 (1), 761340, 2014 | 76 | 2014 |
| Randomized, double-blind, placebo-controlled acute comparator trials of lisdexamfetamine and extended-release methylphenidate in adolescents with attention-deficit … JH Newcorn, P Nagy, AC Childress, G Frick, B Yan, S Pliszka CNS drugs 31, 999-1014, 2017 | 57 | 2017 |
David CoghillDepartments of Paediatrics and Psychiatry, University of MelbourneDirección de correo verificada de dundee.ac.uk
